Variant report
Variant | esv1841939 |
---|---|
Chromosome Location | chr2:141071674-141080797 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs540048318 | chr2:141075232-141075233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs148493926 | chr2:141075253-141075254 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs78227851 | chr2:141075339-141075340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs694813 | chr2:141075369-141075370 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs542307461 | chr2:141075373-141075374 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs562185082 | chr2:141075387-141075388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs374602502 | chr2:141075388-141075389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs551035966 | chr2:141075395-141075396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs376914578 | chr2:141075422-141075423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs564621304 | chr2:141075439-141075440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs533628182 | chr2:141075440-141075441 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs16843764 | chr2:141075479-141075480 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs553445514 | chr2:141075486-141075487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs568537827 | chr2:141075488-141075489 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs188495919 | chr2:141075494-141075495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs193080786 | chr2:141075515-141075516 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs74980772 | chr2:141075519-141075520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs13009775 | chr2:141075564-141075565 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs537436262 | chr2:141075572-141075573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557778431 | chr2:141075577-141075578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs142591878 | chr2:141075645-141075646 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs146489245 | chr2:141075648-141075649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs553797689 | chr2:141075655-141075656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs554762233 | chr2:141075742-141075743 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs573749916 | chr2:141075771-141075772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs183941604 | chr2:141076814-141076815 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs529702175 | chr2:141076816-141076817 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs542915445 | chr2:141076847-141076848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs562701173 | chr2:141076850-141076851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs531801840 | chr2:141076888-141076889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs11674971 | chr2:141076894-141076895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs189442381 | chr2:141076905-141076906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs545773691 | chr2:141076919-141076920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs11674979 | chr2:141076944-141076945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs541516846 | chr2:141077047-141077048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs571281781 | chr2:141077058-141077059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs527263377 | chr2:141077068-141077069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs547125040 | chr2:141077085-141077086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs13022878 | chr2:141077105-141077106 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs536511192 | chr2:141077153-141077154 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs528607251 | chr2:141077160-141077161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs556514097 | chr2:141077175-141077176 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs115956826 | chr2:141077180-141077181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs552865230 | chr2:141077212-141077213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558219086 | chr2:141077242-141077243 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs571019530 | chr2:141077243-141077244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs12692048 | chr2:141077257-141077258 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs12692049 | chr2:141077263-141077264 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs568577152 | chr2:141077269-141077270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs553700235 | chr2:141077282-141077283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Mental retardation | 22214275 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma | 21080181 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Autism | 22543975 | CNVD |
Cancer | 20164920 | CNVD |
Hypertension | 22686481 | CNVD |
Hypospadia | 22686481 | CNVD |
Intellectual disability | 22686481 | CNVD |
Omphalocele | 22686481 | CNVD |
Schizophrenia | 23813976 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Prostate cancer | 22341455 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:141075200-141075800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
2 | chr2:141076800-141077000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr2:141077000-141080400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr2:141080400-141080800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |